AZN: Full-Year 2017 Results

Fri, Feb 02, 2018 08:00 CET

AstraZeneca PLC

2 February 2018 07:00

Full-Year 2017 Results

Encouraging progress made on commercial execution and cost discipline; Product Sales growth in the quarter.

AstraZeneca positioned for Product Sales growth from FY 2018

Please see attached PDF to view the announcement in full.